Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (Nature Immunology, (2019), 20, 11, (1409-1413), 10.1038/s41590-019-0503-1)

Dimitrios C. Mastellos; Anna M. Blom; E. Sander Connolly; Mohamed R. Daha; Brian V. Geisbrecht; Berhane Ghebrehiwet; Piet Gros; George Hajishengallis; V. Michael Holers; Markus Huber-Lang; Taroh Kinoshita; Tom E. Mollnes; Robert A. Montgomery; B. Paul Morgan; Bo Nilsson; Ruben Pio; Daniel Ricklin; Antonio M. Risitano; Ronald P. Taylor; Alberto Mantovani; John P.A. Ioannidis; John D. Lambris

doi:10.1038/s41590-019-0531-x

Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (Nature Immunology, (2019), 20, 11, (1409-1413), 10.1038/s41590-019-0503-1)

Dimitrios C. Mastellos
, Anna M. Blom
, E. Sander Connolly
, Mohamed R. Daha
, Brian V. Geisbrecht
, Berhane Ghebrehiwet
, Piet Gros
, George Hajishengallis
, V. Michael Holers
, Markus Huber-Lang
, Taroh Kinoshita
, Tom E. Mollnes
, Robert A. Montgomery
, B. Paul Morgan
, Bo Nilsson
, Ruben Pio
, Daniel Ricklin
, Antonio M. Risitano
, Ronald P. Taylor
, Alberto Mantovani

John P.A. Ioannidis, John D. Lambris

Allergy and Immunology

Demokritos National Centre for Scientific Research
Lund University
Columbia University
Leiden University
Kansas State University
Utrecht University
University of Pennsylvania
University of Colorado Anschutz Medical Campus
Ulm University
The University of Osaka
University of Oslo
Northern Norway Regional Health Authority
Norwegian University of Science and Technology
New York University
Cardiff University
Uppsala University
University of Navarra
University of Basel
University of Naples Federico II
University of Virginia
IRCCS Istituto Clinico Humanitas - Rozzano (Milano)
Stanford University

Research output: Contribution to journal › Comment/debate

3 Scopus citations

Abstract

In the version of this article initially published, the file for Supplementary Dataset 1 was incorrect. That has now been replaced with the correct file. The error has been corrected in the HTML and PDF versions of the article.

Original language	English
Pages (from-to)	1556
Number of pages	1
Journal	Nature Immunology
Volume	20
Issue number	11
DOIs	https://doi.org/10.1038/s41590-019-0531-x
State	Published - Nov 1 2019

Access to Document

10.1038/s41590-019-0531-x

Cite this

Mastellos, D. C., Blom, A. M., Connolly, E. S., Daha, M. R., Geisbrecht, B. V., Ghebrehiwet, B., Gros, P., Hajishengallis, G., Holers, V. M., Huber-Lang, M., Kinoshita, T., Mollnes, T. E., Montgomery, R. A., Morgan, B. P., Nilsson, B., Pio, R., Ricklin, D., Risitano, A. M., Taylor, R. P., ... Lambris, J. D. (2019). Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (Nature Immunology, (2019), 20, 11, (1409-1413), 10.1038/s41590-019-0503-1). Nature Immunology, 20(11), 1556. https://doi.org/10.1038/s41590-019-0531-x

@article{fd7436e4fb6e4f4e8a8a5b47d7b97e37,

title = "Author Correction: {\textquoteleft}Stealth{\textquoteright} corporate innovation: an emerging threat for therapeutic drug development (Nature Immunology, (2019), 20, 11, (1409-1413), 10.1038/s41590-019-0503-1)",

abstract = "In the version of this article initially published, the file for Supplementary Dataset 1 was incorrect. That has now been replaced with the correct file. The error has been corrected in the HTML and PDF versions of the article.",

author = "Mastellos, \{Dimitrios C.\} and Blom, \{Anna M.\} and Connolly, \{E. Sander\} and Daha, \{Mohamed R.\} and Geisbrecht, \{Brian V.\} and Berhane Ghebrehiwet and Piet Gros and George Hajishengallis and Holers, \{V. Michael\} and Markus Huber-Lang and Taroh Kinoshita and Mollnes, \{Tom E.\} and Montgomery, \{Robert A.\} and Morgan, \{B. Paul\} and Bo Nilsson and Ruben Pio and Daniel Ricklin and Risitano, \{Antonio M.\} and Taylor, \{Ronald P.\} and Alberto Mantovani and Ioannidis, \{John P.A.\} and Lambris, \{John D.\}",

note = "Publisher Copyright: {\textcopyright} 2019, Springer Nature America, Inc.",

year = "2019",

month = nov,

day = "1",

doi = "10.1038/s41590-019-0531-x",

language = "English",

volume = "20",

pages = "1556",

journal = "Nature Immunology",

issn = "1529-2908",

number = "11",

}

Mastellos, DC, Blom, AM, Connolly, ES, Daha, MR, Geisbrecht, BV, Ghebrehiwet, B, Gros, P, Hajishengallis, G, Holers, VM, Huber-Lang, M, Kinoshita, T, Mollnes, TE, Montgomery, RA, Morgan, BP, Nilsson, B, Pio, R, Ricklin, D, Risitano, AM, Taylor, RP, Mantovani, A, Ioannidis, JPA & Lambris, JD 2019, 'Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (Nature Immunology, (2019), 20, 11, (1409-1413), 10.1038/s41590-019-0503-1)', Nature Immunology, vol. 20, no. 11, pp. 1556. https://doi.org/10.1038/s41590-019-0531-x

Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (Nature Immunology, (2019), 20, 11, (1409-1413), 10.1038/s41590-019-0503-1). / Mastellos, Dimitrios C.; Blom, Anna M.; Connolly, E. Sander et al.
In: Nature Immunology, Vol. 20, No. 11, 01.11.2019, p. 1556.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Author Correction

T2 - ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (Nature Immunology, (2019), 20, 11, (1409-1413), 10.1038/s41590-019-0503-1)

AU - Mastellos, Dimitrios C.

AU - Blom, Anna M.

AU - Connolly, E. Sander

AU - Daha, Mohamed R.

AU - Geisbrecht, Brian V.

AU - Ghebrehiwet, Berhane

AU - Gros, Piet

AU - Hajishengallis, George

AU - Holers, V. Michael

AU - Huber-Lang, Markus

AU - Kinoshita, Taroh

AU - Mollnes, Tom E.

AU - Montgomery, Robert A.

AU - Morgan, B. Paul

AU - Nilsson, Bo

AU - Pio, Ruben

AU - Ricklin, Daniel

AU - Risitano, Antonio M.

AU - Taylor, Ronald P.

AU - Mantovani, Alberto

AU - Ioannidis, John P.A.

AU - Lambris, John D.

PY - 2019/11/1

Y1 - 2019/11/1

N2 - In the version of this article initially published, the file for Supplementary Dataset 1 was incorrect. That has now been replaced with the correct file. The error has been corrected in the HTML and PDF versions of the article.

AB - In the version of this article initially published, the file for Supplementary Dataset 1 was incorrect. That has now been replaced with the correct file. The error has been corrected in the HTML and PDF versions of the article.

UR - https://www.scopus.com/pages/publications/85074109078

U2 - 10.1038/s41590-019-0531-x

DO - 10.1038/s41590-019-0531-x

M3 - Comment/debate

C2 - 31605100

AN - SCOPUS:85074109078

SN - 1529-2908

VL - 20

SP - 1556

JO - Nature Immunology

JF - Nature Immunology

IS - 11

ER -

Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (Nature Immunology, (2019), 20, 11, (1409-1413), 10.1038/s41590-019-0503-1)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this